Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Oct 25 2021

Full Issue

Covid Shot For Kids May Be Just Weeks Away After FDA Review Of Pfizer Data

The Food and Drug Administration said Friday that its review of Pfizer's covid vaccine found it to be highly effective at preventing symptomatic infections in children ages 5 to 11 and causes no unexpected safety issues. Dr. Anthony Fauci expects the shot to be authorized for that age group in November.

USA Today: Vaccine Appears To Work In Young Kids, FDA Says

Federal health regulators said for the first time late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues. The Food and Drug Administration posted its analysis of Pfizer’s data ahead of a public meeting next week to debate whether the shots are ready for the nation’s roughly 28 million children ages 5 to 11. The agency will ask a panel of outside vaccine experts to vote on that question and is expected to authorize the vaccine for young children as early as next week. (Santucci and Carless, 10/23)

The Washington Post: FDA Review Appears To Pave The Way For Pfizer-BioNTech Vaccine For Children 5 To 11

The review found that for four scenarios that were weighed, “the benefits of the Pfizer-BioNTech COVID-19 Vaccine 2-dose primary series clearly outweigh the risks.” But in one, when the virus was at its lowest levels, there could be more hospitalizations related to a rare heart side effect associated with the vaccine than the number of hospitalizations prevented from covid-19, the illness caused by the virus. Even then, the review found, “the overall benefits of the vaccine may still outweigh the risks under this lowest incidence scenario” because of how hospitalized cases of the two conditions differ. The vaccine-related myocarditis cases have tended to resolve in a few days, unlike covid-19 infections, which can lead to death. (Johnson and McGinley, 10/22)

Also —

Reuters: Fauci Says Vaccines For Kids Between 5-11 Likely Available In November 

Vaccines for kids between the ages of 5 and 11 will likely be available in the first half of November, top U.S. infectious disease expert Anthony Fauci said on Sunday, predicting a timetable that could see many kids getting fully vaccinated before the end of the year. "If all goes well, and we get the regulatory approval and the recommendation from the CDC, it's entirely possible if not very likely that vaccines will be available for children from 5 to 11 within the first week or two of November," Fauci said in an interview with ABC's This Week. (Pamuk, 10/24)

CNN: How To Talk To Your Younger Kids About The Covid-19 Vaccine 

An 11-year-old girl was petrified -- her word -- of needles, so much so that she didn't want to talk about it with me. She couldn't talk about it without becoming visibly upset. Her heart raced, her breathing became rapid, and her stomach hurt when she tried to answer my questions. So, we backed up and started from the beginning. I first had her look at cartoon images of children getting vaccines. When I asked her how it felt to do that, she rolled her eyes and reminded me that it wasn't real. Next, I had her look at photos of medical needles. She reported that she didn't like the pictures, but she could handle looking at them. (Hurley, 10/25)

In related news about children —

Politico: CDC Director Encourages Halloween Trick-Or-Treating 

CDC Director Rochelle Walensky on Sunday encouraged families to celebrate Halloween and other holidays amid the Covid-19 pandemic, though still urged “prevention strategies.“ Speaking to host Chris Wallace on “Fox News Sunday,” she said, “I would say put on those costumes, stay outside and enjoy your trick-or-treating.“ (Cohen, 10/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF